Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea

Eye and Contact Lens

Volumn 32, Issue 4, 2006, Pages 161-165

  Ly, Linda T ^a   Cavanagh, H Dwight ^b   Petroll, W Matthew ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Benzalkonium chloride; Confocal microscopy; Cornea; Fluoroquinolones

Indexed keywords

GATIFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; EYE DROPS; HETEROCYCLIC COMPOUND; MEMBRANE PROTEIN; PHOSPHOPROTEIN; QUINOLINE DERIVATIVE; QUINOLONE DERIVATIVE; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL SIZE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG EXPOSURE; EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAINING; STATISTICAL ANALYSIS; TIGHT JUNCTION; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

ANIMALS; AZA COMPOUNDS; EPITHELIUM, CORNEAL; FLUOROQUINOLONES; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; OPHTHALMIC SOLUTIONS; PHOSPHOPROTEINS; QUINOLINES; RABBITS;

EID: 33748452124     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icl.0000185041.08549.45     Document Type: Article

References (28)

1. Recchia FM, Busbee BG, Pearlman RB, et al. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol 2005;123:341-346.
2. Mather R, Karenchak LM, Romanowski EG, et al. Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463-466.
3. Pestova E, Millichap JJ, Noskin GA, et al. Intracellular targets of moxifloxacin: A comparison with other fluoroquinolones. J Antimicrob Chemother 2000;45:583-590.
4. Becquet F, Goldschild M, Moldovan MS, et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res 1998;17:419-425.
5. Cha S-H, Lee J-S, Oum B-S, et al. Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro. Clin Exp Ophthalmol 2004;32:180-184.
6. Ishibashi T, Yokoi N, Kinoshita S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma 2003;12:486-490.
7. Ichijima H, Petroll WM, Jester JV, et al. Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea 1992;11:221-225.
8. Herrygers LA, Noecker RJ, Lane LA, et al. Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols. Cornea 2005;24:66-71.
9. Kovoor TA, Kim AS, McCulley JP, et al. Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy. Eye Contact Lens 2004;30:90-94.
10. Donnenfield E, Perry HD, Chruscicki DA, et al. A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability. Curr Med Res Opin 2004;20:1753-1758.
11. Durrie DS, Trattler W. A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK. J Ocul Pharmacol Ther 2005;21:236-241.
12. McLaughlin B, Caldwell R, Sasaki Y, et al. Freeze-fracture quantitative comparison of rabbit corneal epithelial and endothelial membranes. Curr Eye Res 1985;4:951-961.
13. Petroll WM, Jester JV, Cavanagh HD. In vivo confocal imaging: general principles and applications. Scanning 1994;16:131-149.
14. Petroll WM, Jester JV, Cavanagh HD. Quantitative three dimensional confocal imaging of the cornea in situ and in vivo: System design and calibration. Scanning 1996;18:45-49.
15. Li H-F, Petroll WM, Maurer JK, et al. Epithelial and corneal thickness measurements by in vivo confocal microscopy through focusing. Curr Eye Res 1997;16:214-221.
16. Moller-Peterson T, Vogel M, Li H-F, et al. Quantification of stromal thinning, epithelial thickness, and corneal haze after photorefractive keratectomy using in vivo confocal microscopy. Ophthalmology 1997;104:360-368.
17. Moller-Peterson T, Li H-F, Petroll WM, et al. Confocal microscopic characterization of wound repair after photorefractive keratectomy. Invest Ophthalmol Vis Sci 1998;39:487-501.
18. Li J, Jester JV, Cavanagh HD, et al. On-line 3-dimensional confocal imaging in vivo. Invest Ophthalmol Vis Sci 2000;41:2945-2953.
19. Barry PA, Petroll WM, Andrews PM, et al. The spatial organization of corneal endothelial cytoskeletal proteins and their relationship to the apical junctional complex. Invest Ophthalmol Vis Sci 1995;36:1115-1124.
20. Kowalski RP, Dhaliwal DK, Karenchak LM, et al. Gatifloxacin and moxifloxacin: An in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 2003;136:500-505.
21. Kowalski RP, Romanowski EG, Mah FS, et al. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol 2004;138:33-37.
22. Schlech BA, Sutton S, Rosenthal RA, et al. Antimicrobial preservative effectiveness of Vigamox. In: Program and abstracts of the Annual Meeting of the Association for Research in Vision and Ophthalmology; April 24-29, 2004; Ft. Lauderdale, FL. Abstract 4913.
23. Jester JV, Maurer JK, Petroll WM. Application of in vivo confocal microscopy to the understanding of surfactant-induced ocular irritation. Toxicol Pathol 1996;24:412-428.
24. Owen GR, McCarey BE, Edelhauser HF. Non-Invasive fluorophotometry assessment of corneal epithelial permeability after exposure to Vigamox or Zymar. In: Program and abstracts of the Annual Meeting of the Association for Research in Vision and Ophthalmology; May 1-5, 2005; Ft. Lauderdale, FL. Abstract 4092.
25. Dembinska O, Stout KR, Podval J, et al. Corneal epithelial barrier function following the exposure to Vigamox and Zymar in ex vivo model of corneal permeability. In: Program and abstracts of the Annual Meeting of the Association for Research in Vision and Ophthalmology; May 1-5, 2005; Ft. Lauderdale, FL. Abstract 4901.
26. Owen GR, Dembinska O, Stout KR, et al. Corneal penetration and changes in corneal permeability of moxifloxacin versus gatifloxacin. In: Program and abstracts of the Annual Meeting of the Association for Research in Vision and Ophthalmology; April 24-29, 2004; Ft. Lauderdale, FL. Abstract 4910.
27. Levine JM, Noecker RJ, Lane LA, et al. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J Cataract Refractive Surg 2004;30:2177-2182.
28. Kim DH, Stark WJ, O'Brien TP. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery. Curr Med Res Opin 2005;21:93-94.